Authors’ Reply

---

Eur Rev Med Pharmacol Sci 2026; 30 (4): 131-132
DOI: 10.26355/eurrev_202604_37750

Reply to: “Putative underlying mechanisms of lipid emulsion treatment for aluminum phosphide poisoning”

M. Singh Bhatia, R. Attri, A. Saroch, A. Kumar Pannu, N. Singla, S. Chandrabhan Sharda

Eur Rev Med Pharmacol Sci 2024; 28 (10): 3477-3478
DOI: 10.26355/eurrev_202405_36281

Reply letter to Adeli and Jazi – “Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion”

W. Tang, D. Zhu, F. Wu, J.-F. Xu, J.-P. Yang, Z.-P. Deng, X.-B. Chen, A. Papi, J.-M. Qu

Eur Rev Med Pharmacol Sci 2024; 28 (9): 3295-3296
DOI: 10.26355/eurrev_202405_36174

Reply Letter to Chiavarini et al – “Association between nutritional indices and mortality after hip fracture: a systematic review and meta-analysis”

N. Liu, L. Lv, J. Jiao, Y. Zhang, X.-L. Zuo

Eur Rev Med Pharmacol Sci 2022; 26 (23): 8635-8636
DOI: 10.26355/eurrev_202212_30533

Reply Letter – to Urso et al “Comment on: Comparative dissolution profiles of two anti-emetic delayed release dosage forms of doxylamine and pyridoxine: Xonvea® tablets vs. Cariban® capsules”

C. Alcocer, E. Rom, P.-A. Regidor

Eur Rev Med Pharmacol Sci 2022; 26 (16): 5633-5634
DOI: 10.26355/eurrev_202208_29495

Reply Letter to Recommended revisions to the article “Prehabilitation and heart failure”

S. Giovannini, L. Castelli, C. Loreti, F. Brau, L. Biscotti, R. Bernabei

Eur Rev Med Pharmacol Sci 2022; 26 (9): 3061-3061
DOI: 10.26355/eurrev_202205_28722

Reply Letter – Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

J.F. de Carvalho, L.C. Behrmann Martins, A.F. Cardoso, Y. Shoenfeld

Eur Rev Med Pharmacol Sci 2022; 26 (3): 733-733
DOI: 10.26355/eurrev_202202_27977

Reply Letter – Side effects to BNT162b2 can be severe

I.N. Martínez-Salazar

Eur Rev Med Pharmacol Sci 2021; 25 (23): 7193-7194
DOI: 10.26355/eurrev_202112_27410

Reply Letter – Polypharmacy is a determinant of hospitalization in Parkinson’s disease

S. Giovannini, A. Laudisio, L. Navarini, C. Loreti, L. Biscotti, L. Padua, R. Bernabei, G. Zuccalà

Eur Rev Med Pharmacol Sci 2021; 25 (17): 5329-5329
DOI: 10.26355/eurrev_202109_26639

Reply Letter – Cupping therapy: a final therapeutic step in Persian medicine

C. Guarneri

Eur Rev Med Pharmacol Sci 2021; 25 (16): 5073-5074
DOI: 10.26355/eurrev_202108_26518

Reply letter to comment on “Impact of insulin use on outcomes of diabetic breast cancer patients: a systematic review and meta-analysis”

L. Wang, H.-J. Zhang, Y.-F. Liu, G.-Y. Chen

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4445-4445
DOI: 10.26355/eurrev_202107_26232

Reply Letter – Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

S.A. Meo, D.C. Klonoff, J. Akram

Eur Rev Med Pharmacol Sci 2021; 25 (9): 3403-3404
DOI: 10.26355/eurrev_202105_25817

Reply Letter – SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy

S. Greco, A. De Giorgi, N. Fabbri, A. Passaro

Eur Rev Med Pharmacol Sci 2021; 25 (5): 2161-2162
DOI: 10.26355/eurrev_202103_25203

Reply Letter – “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis”

A. De Vito, G. Madeddu

Eur Rev Med Pharmacol Sci 2020; 24 (22): 11470-11470
DOI: 10.26355/eurrev_202011_23785

Reply to the Letter “Methodological issues in multivariable logistic regression”

N. Kose, F. Akin, T. Yıldırım, G. Ergun, I. Altun

Eur Rev Med Pharmacol Sci 2020; 24 (12): 6482-6483
DOI: 10.26355/eurrev_202006_21629

Reply Letter – COVID-19 (Novel Coronavirus 2019) – Recent trends

S. Kannan, P. Shaik Syed Ali Pakeer, A. Sheeza Ali, K. Hemalatha

Eur Rev Med Pharmacol Sci 2020; 24 (7): 3446-3447
DOI: 10.26355/eurrev_202004_20800

Reply to the Letter – “The development of Brugada syndrome phenotype is multifactorial, combining genetic and environmental factors”

P.E. Maltese, E. Aldanova, N. Kriuchkova, A. Averianov, E. Manara, S. Paolacci, A. Bruson, R. Miotto, M. Sartori, G. Guerri, M. Zuntini, G. Marceddu, S. Tezzele, K. Tadtaeva, A. Chernova, N. Aksyutina, S. Nikulina, S. Nodari, M. Bertelli

Eur Rev Med Pharmacol Sci 2017; 21 (20): 4476-

Reply to the letter: HIPEC and the necessary hyperthermia: do we still need the open abdomen?

D. Di Miceli

Eur Rev Med Pharmacol Sci 2016; 20 (11): 2185-2186

Non-invasive electrocardiographic methods for assessment of atrial conduction heterogeneity in ankylosing spondylitis

H. Aksoy, S. Okutucu, B.Y. Sayin, A. Oto

Eur Rev Med Pharmacol Sci 2016; 20 (7): 1223-

Reply to Klinger et al

D. Ribuffo, G.M. Di Benedetto, M. Greco

Eur Rev Med Pharmacol Sci 2015; 19 (24): 4940-

Erratum

E.I. Cekirdekci